Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118739483 | 11873948 | 3 | F | 20160906 | 20151229 | 20160906 | PER | US-BRISTOL-MYERS SQUIBB COMPANY-BMS-2015-090168 | BRISTOL MYERS SQUIBB | 42.00 | YR | M | Y | 0.00000 | 20160906 | OT | US | US |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 118739483 | 11873948 | 1 | PS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 10 MG, QD | Y | 21436 | 10 | MG | QD | ||||||
| 118739483 | 11873948 | 2 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 20 MG, QD | Y | 21436 | 20 | MG | QD | ||||||
| 118739483 | 11873948 | 3 | SS | ABILIFY | ARIPIPRAZOLE | 1 | Unknown | 15 MG, QD | Y | 21436 | 15 | MG | QD |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 118739483 | 11873948 | 1 | Apathy |
Outcome of event
| no results found |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 118739483 | 11873948 | Product use issue | |
| 118739483 | 11873948 | Somnolence |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| no results found |